Home LiteratureArticle Details
PMID: 28097362 Published · ppublish English Guideline Journal Article Research Support, Non-U.S. Gov't

Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.

JAMA ·Vol. 317 ·No. 2 ·2017-00-10 ·Pages 183-189

US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phillips WR, Phipps MG, Pignone MP, Silverstein M, Tseng CW

Abstract

Neural tube defects are among the most common major congenital anomalies in the United States and may lead to a range of disabilities or death. Daily folic acid supplementation in the periconceptional period can prevent neural tube defects. However, most women do not receive the recommended daily intake of folate from diet alone. To update the 2009 US Preventive Services Task Force (USPSTF) recommendation on folic acid supplementation in women of childbearing age. In 2009, the USPSTF reviewed the effectiveness of folic acid supplementation in women of childbearing age for the prevention of neural tube defects in infants. The current review assessed new evidence on the benefits and harms of folic acid supplementation. The USPSTF assessed the balance of the benefits and harms of folic acid supplementation in women of childbearing age and determined that the net benefit is substantial. Evidence is adequate that the harms to the mother or infant from folic acid supplementation taken at the usual doses are no greater than small. Therefore, the USPSTF reaffirms its 2009 recommendation. The USPSTF recommends that all women who are planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400-800 µg) of folic acid. (A recommendation).

MeSH Terms
Advisory Committees Dietary Supplements/adverse effects Female Folic Acid/administration & dosage,adverse effects Humans Neural Tube Defects/prevention & control Pregnancy Recommended Dietary Allowances Risk Assessment United States Vitamin B Complex/administration & dosage,adverse effects
Chemicals
Vitamin B Complex Folic Acid
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
US Preventive Services Task Force
Bibbins-Domingo Kirsten
University of California, San Francisco.
Grossman David C
Group Health Research Institute, Seattle, Washington.
Curry Susan J
University of Iowa, Iowa City.
Davidson Karina W
Columbia University, New York, New York.
Epling John W
State University of New York Upstate Medical University, Syracuse.
García Francisco A R
Pima County Department of Health, Tucson, Arizona.
Kemper Alex R
Duke University, Durham, North Carolina.
Krist Alex H
Fairfax Family Practice Residency, Fairfax, Virginia9Virginia Commonwealth University, Richmond.
Kurth Ann E
Yale University, New Haven, Connecticut.
Landefeld C Seth
University of Alabama at Birmingham.
Mangione Carol M
University of California, Los Angeles.
Phillips William R
University of Washington, Seattle.
Phipps Maureen G
Brown University, Providence, Rhode Island.
Pignone Michael P
University of Texas at Austin.
Silverstein Michael
Boston University, Boston, Massachusetts.
Tseng Chien-Wen
University of Hawaii, Manoa.
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
1538-3598
Published
2017-00-10
Pages
183-189
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Corrections
SummaryForPatientsIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com